Monitoring with Reveal® XT ICM
Detecting AF with Reveal® XT ICM
You know that AF can be challenging to diagnose. It is often paroxysmal and asymptomatic, making detection difficult.1 Reveal XT Insertable Cardiac Monitor (ICM) is designed to help you detect AF in cryptogenic stroke patients through long-term, continuous, automatic ECG monitoring.
With Reveal ICM, you can monitor patients for up to three years.
The Reveal ICM:
- Records ECG data during an actual episode or symptom marked episode
- Has no wires or leads
- Records in-office or remote data transmissions via the Medtronic CareLink® Network.
- Reveal DX and XT ICMs have been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please see Reveal XT clinician manual for more details.
You can find a cardiologist in your area who will partner with you, allowing you to use the Reveal ICM to help detect AF in your cryptogenic stroke patients.
1. Savelieva I, Camm AJ. J Invterv Card Electrophysiol. 2000;4:369-382.
Proven Effective
The Reveal ICM:
- Has an overall accuracy for detecting AF burden at 98.5%.1
- Detects AF in 96.1% of patients with AF.1
- Safely allows MRI. Reveal ICM has been demonstrated to pose no known hazards in a specified MR environment with specified conditions of use. Please see the Reveal XT Clinician Manual for more details.
References:
1. Hindricks G, et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation—results of the XPECT trial. Circ Arrhythm Electrophysiol. http://circep.ahajos G, Pournals.org. Published online Feb. 16, 2010.
Risks
Potential complications include, but are not limited to, device rejection phenomena (including local tissue reaction), device migration, infection, and erosion through the skin.l ICM is an outpatient procedure. You can find an implanting physician in your area.
Implant Procedure
The procedure to place the Reveal ICM follows these general steps:
- The Reveal ICM is placed under the skin in the upper chest area.
- During the brief procedure, the area is numbed with local anesthesia
- A small incision (approximately 2 cm) is made, and the monitor is inserted
Placing the Reveal ICM is an outpatient procedure. You can find an implanting physician in your area.
Indications for Use
Reveal Indications for Use
The Reveal XT ICM is indicated in the following cases:
- Patients with clinical syndromes or situations at increased risk for cardiac arrhythmias.
- Patients who experience transient symptoms such as dizziness, palpitation, syncope, and chest pain that may suggest a cardiac arrhythmia.
Be Informed
Hear what your colleagues are saying about Cryptogenic Stroke
and AF